Trials / Completed
CompletedNCT03614520
Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Parc de Salut Mar · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims at studying in depth the absorption and metabolism of phenolic compounds of olive oil, wine and beer. This study is divided into 2 sub-studies in order to evaluate each one of the objectives.
Detailed description
The study is divided in two sub-studies to explore each objective. One the one hand, a group of people will drink olive oil, or wine, or both. This is done to see if combining these two drinks will improve the absorption and bioavailibility of phenolic compounds that they contain, promoting by synergy their antioxidant activity at a postprandial level. The main compounds studied are the Resveratrol (RSVT), the Hydroxytyrosol (HT), tyrosol (TIR) and their metabolits. One the other hand, an group of people will drink 3 different beers ( with 3 different degrees of alcohol), or wine, in order to study the absorption of TIR in relation to the alcohol degree. It also aims at assessing if the gas contained in beer contributes to TIR absorption. At different times after the administration of drinks, urine and blood samples will be collected.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Administration of olive oil | 25 mL of extra virgin olive oil |
| OTHER | Administration of red wine | 150 mL or Red Wine |
| OTHER | Combination of red wine and olive oil | 150 mL of Red wine + 25 mL of Extra Virgin Olive oil will be administred at the same time |
| OTHER | Water | Mineral water will be given as placebo |
| OTHER | Dark beer | 250 mL of IPA beer (alcohol 8.5% vol) |
| OTHER | Light Beer | 250 mL of blonde ale beer (alcohol 4,5% vol) |
| OTHER | Alcohol free Beer | 250 mL of alcohol free beer (alcohol 0.0% vol) |
Timeline
- Start date
- 2018-07-09
- Primary completion
- 2019-02-27
- Completion
- 2019-02-27
- First posted
- 2018-08-03
- Last updated
- 2020-03-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03614520. Inclusion in this directory is not an endorsement.